This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (22)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Herbert Kleber, MD; J. Kevin Kinsella, EdD, MPH; Charles Riordan, MD; Sarah Greaves, MS; Donald Sweeney, PhD, MD

Arch Gen Psychiatry. 1974;30(1):37-42.

Abstract
This study evaluated the clinical efficacy of cyclazocine when used as part of a direct-service drug-abuse program characterized by relatively low-treatment intervention. Standard induction and maintenance schedules were devised and procedures were developed to evaluate results.

Twenty-seven patients were administered cyclazocine over a tenmonth period with 42% being retained. Results suggest that, although cyclazocine was accepted by a majority (75%) of the sample, the nature and extent of side effects during induction may limit its usefulness of a larger scale. The overall program design holds promise as a model for future use of narcotic antagonists.

Author Affiliations
New Haven, Conn

From the Department of Psychiatry, Yale University School of Medicine and the Drug Dependence Unit, Connecticut Mental Health Center, New Haven.

Footnotes
Accepted for publication Oct 15, 1973.

Reprint requests to Connecticut Mental Health Center, PO Box 1842, 34 Park St, New Haven, CT 06508 (Dr. Kleber).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Naltrexone and Cyclazocine: A Controlled Treatment Study
Brahen et al.
Arch Gen Psychiatry 1977;34:1181-1184.
ABSTRACT  

A Behavioral Paradigm for the Evaluation of
Meyer et al.
Arch Gen Psychiatry 1976;33:371-377.
ABSTRACT